Xynomic Pharmaceuticals, Inc. (Xynomic)

Oncology Corporate Profile

Stock Performance


HQ Location

1910 Thomes Ave.
Cheyenne, WY 82001

Company Description

Xynomic Pharmaceuticals, Inc. is a US emerging biopharmaceutical company founded by US-China industry veterans and successful entrepreneurs. Xymonic Pharma focuses on in-licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. The founding executives worked at leading multinational biopharmaceutical companies (Schering, Eli Lilly, Merck, and Roche) in R&D roles. The founders also had successful entrepreneurial experiences including founding, building, and exiting successful US-China biopharmaceutical companies.

Website: http://xynomicpharma.com/en/506-11/

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
abexinostathistone deacetylase (HDAC) inhibitorDiffuse Large B-Cell Lymphoma (DLBCL)II
abexinostathistone deacetylase (HDAC) inhibitorDouble-Refractory Follicular LymphomaII
abexinostathistone deacetylase (HDAC) inhibitorPeripheral T-cell LymphomaII
abexinostathistone deacetylase (HDAC) inhibitorGliomaI
abexinostathistone deacetylase (HDAC) inhibitorRenal cell carcinoma (RCC)I

View additional information on product candidates here »

Source: http://xynomicpharma.com/en/506-11/

Recent News Headlines

There are no news items to display